EFPIA - NEWSLETTER

Trouble reading this email? View it in your browser


		EFPIA Newsletter 17 July 2025

News

EFPIA submits GDPR Code of Conduct for formal assessment
16 July 2025

EFPIA is pleased to announce the submission of its GDPR Code of Conduct on Clinical Trials and Pharmacovigilance to... Read more

Clinical trial community seek urgent implementation of Life Science Strategy, as research becomes...
16 July 2025

A broad group of organisations, working in the European clinical trial sector, have issued a warning to policy makers,... Read more

ECHoS webinar - Debunking the myths: Conversations on collaboration with the Pharmaceutical Industry

The ECHoS webinar “Debunking the myths: Conversations on collaboration with the Pharmaceutical Industry” focused on how National Cancer Mission Hubs (NCMHs) can build meaningful and effective partnerships with the pharmaceutical industry to accelerate cancer innovation and improve patient outcomes across Europe.

Watch it here.

Events

From Science to Access: Where are we in cancer care in 2025?
04 September 2025 (Brussels, Belgium)

Hosted by MEP Romana Jerković, this event will bring together policymakers, researchers, healthcare professionals, patients... Read more

Decentralised clinical trials: Turning experience into established practice
04 September 2025 (Virtual event)

Join us for a webinar that brings together key voices from across the EU healthcare landscape to explore what it takes... Read more

Discover EFPIA position paper on Randomised Pragmatic Trials

EFPIA’s latest position paper explores how Randomised Pragmatic Trials (RPTs) can revolutionise the way we generate evidence for regulatory decisions. Moving beyond the traditional clinical trial model, RPTs harness real-world data to deliver more inclusive, efficient, and patient-centric research.

Read more here.

What we are reading

Pharmaceutical innovation: Europe and the American challenge
On 15 July 2025 (Ile Sole 24 Ore)

Stefan Oelrich, President Bayer Pharmaceuticals and President Efpia, on the occasion of Bayer Italia's 125th anniversary:... Read more

Stop national solo efforts in Europe!
On 14 July 2025 (Handelsblatt)

Europe is under pressure. Geopolitical tensions are rising. Economic uncertainty is growing. The US is using trade... Read more

Trump’s pharma strategy explained: ‘It’s simple – just incredibly complicated’
On 14 July 2025 (Euractiv)

Pharma is exempt – for now. But 200% tariffs could hit in one to one-and-a-half years, warns Swiss analyst.

China biotech’s stunning advance is changing the world’s drug pipeline
On 13 July 2025 (Bloomberg)

Chinese biotech's advance has been as ferocious as the nation's breakthrough efforts in AI and EVs, eclipsing the... Read more

ERDERA interviews Magda Cheblus, Executive Director of Science Policy & Regulatory Affairs...
On 10 July 2025 (ERDERA)

The notion that public-private collaboration is inherently problematic doesn’t align with current realities. Not... Read more

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
E-mail:Communications@efpia.eu